Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • O vs MRNA✓SelectedUSD · MRNAO vs MRNA performance historyLatest closeAs of+0.64%11/20
Stock and ETF performance explorer

O vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+33.3%
MRNA return
+786.4%
Excess return
-753.1%
Maximum drawdown
-48.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.6%-2.2%+2.8%+0.7%
7D-1.3%-12.7%+11.4%-1.3%
30D+5.3%-20.7%+26.0%+5.4%
3M-6.8%+46.3%-53.1%-7.1%
6M-4.2%+305.2%-309.4%-5.5%
YTD+7.6%+561.2%-553.6%+5.8%
1Y+8.8%+772.1%-763.3%+6.7%
3Y+28.7%+147.0%-118.3%+26.6%
5Y+6.3%-26.1%+32.3%+2.8%
All+33.3%+786.4%-753.1%+54.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling